Bio:
Thank you for bringing this to our attention. I had forgotten about the neurological disorders that may be caused by Zika and other viruses. This article you cite is of particular interest to me since my sister died at the age of 22 from encephalomyelitis and the neurological problems caused by that disease.
These are desperate times. People are frightened by the spread of Coronavirus. Notably, we have also seen a dramatic impact taking place in the stock market. Societies and governments, unfortunately, often do not respond except when faced with a crisis. We are, at the very least, on the verge of catastrophe with the Coronavirus virus that is also inflicting economic damage and political consequences.
AVXL 2-73 has passed safety tests. If AVXL 2-73 clinical trials continue to show promise for AD, Rett, then PDD with numerous scientific articles also indicating that it may be beneficial for other diseases; this may help in the approval of the drug. Or, at least it may mean more financial backing to move AVXL 2-73 forward. See also Plexrex's post this morning that quotes Kevin Francis, Ph.D., with Sanford Research: "And yes I agree, Anavex’s portfolio of compounds has a lot of potential for a number of conditions. My hope is we can apply some of these products to a number of diseases..."
In desperate circumstances, people abandon their usual complacent concerns such as, in the case of drug testing, following the traditional slow and cautious drug approval process. And after all, AVXL 2-73 is safe. It shows promise in helping to combat serious disorders, and it should be of even more interest as we face a potential pandemic with no known drugs available to be of much, if any benefit.
